As part of Sanofi’s commitment to developing a diverse portfolio of best-in-class vaccines, the company has announced it entered into a co-exclusive licensing agreement with, and minority equity investment (<5%) in, Novavax, a biotechnology company headquartered in Maryland, US.
Latham & Watkins LLP advised Sanofi in the agreement, with a healthcare and life sciences team led by New York partner Aaron Gardner with associate Robert Yeh. Advice on the minority equity investment was provided by New York partner Nathan Ajiashvili, with associates Kaj Nielson and Sheen Moaleman. Century City partner Andrew Clark advised on corporate and due diligence matters, with counsel Darryl Steensma and associates Brianna Dollinger, Michael Sweeney, Drew O’Sullivan, Mark Goshgarian, Gary Mo, Diana Chung, Enrique Covarrubias, Aldrich Huang, and Patrick Chew.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
